Stock Alert: Histogen (HSTO) Falling 8.97% in Pre-Market Hours for August 5

Equities Staff  |

Shares of Histogen Inc (NASDAQ:HSTO) are on the move in pre-market trading for August 5.

Ahead of the market's open, Histogen stock has fallen 8.97% from the previous session’s close.

Histogen was up $0.37 in the last session and aims for another gain today.

For technical charts, analysis, and more on Histogen visit the company profile.

Pre-market prices and movements as of 08:16:02 est.

About Histogen Inc

Histogen Inc. is a clinical-stage therapeutics company focused on developing potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function. Histogen's innovative technology platform utilizes cell conditioned media and extracellular matrix materials produced by hypoxia-induced multipotent cells. Histogen's proprietary, reproducible manufacturing process provides targeted solutions across a broad range of therapeutic indications including hair growth, dermal rejuvenation, joint cartilage regeneration and spinal disk repair.

To get more information on Histogen Inc and to follow the company's latest updates, you can visit the company's profile page here: Histogen Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

The Strong Dollar Is a Problem for Stocks
3 Ways Finance Teams Can Navigate Inflation Through Automation



Market Movers

Sponsored Financial Content